1. Epidemiology of carbapenem-resistant Gram-negative infections globally;Brink;Curr Opin Infect Dis,2019
2. World Health Organization (2020). Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. https://www.who.int/publications/i/item/9789240005587. (Accessed November 30, 2022)
3. The crisis of carbapenemase-mediated carbapenem resistance across the human-animal-environmental interface in India;Das;Infect Dis Now,2022
4. Extended spectrum- and carbapenemase-based β-lactam resistance in the Arabian Peninsula — a descriptive review of recent years;Hays;Antibiotics (Basel),2022
5. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: description of a decade-long trend;Balkhair;Int J Infect Dis,2019